UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial

European journal of cancer (1990), 2004-05, Vol.40 (7), p.988-997

2004

Volltextzugriff (PDF)

Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes : a new approach to cancer immunotherapy

Cancer research (Chicago, Ill.), 1990-12, Vol.50 (23), p.7450-7456

1990

Volltextzugriff (PDF)

Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum

European journal of cancer (1990), 1997-03, Vol.33 (3), p.379-384

1997

Volltextzugriff (PDF)

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

European journal of cancer (1990), 1992, Vol.28 (2), p.450-457

1992

Volltextzugriff (PDF)

Clinical phase I study with one-hour paclitaxel infusion

Annals of oncology, 1998-05, Vol.9 (5), p.569-572

1998

Volltextzugriff (PDF)

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

Supportive care in cancer, 1999-09, Vol.7 (5), p.354-361

1999

Volltextzugriff (PDF)

Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma

Annals of oncology, 1996-04, Vol.7 (4), p.416-418

1996

Volltextzugriff (PDF)

Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial

Annals of surgical oncology, 2006-12, Vol.13 (12), p.1702-1710

2006

Volltextzugriff (PDF)

Operative und medikamentöse Therapie des frühen Ovarialkarzinoms

Onkologie (Heidelberg, Germany), 2002-11, Vol.8 (11), p.1187-1200

Meerpohl, H. G

2002

Volltextzugriff (PDF)

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer

Annals of oncology, 1997-04, Vol.8 (4), p.355-361

1997

Volltextzugriff (PDF)

Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis

Oncology, 1996-01, Vol.53 Suppl 1, p.46

1996

Volltextzugriff (PDF)

Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease

Gynecologic oncology, 1997-07, Vol.66 (1), p.75-84

1997

Volltextzugriff (PDF)

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

Annals of oncology, 2018-01, Vol.29 (1), p.178-185

2018

Volltextzugriff (PDF)

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer

Seminars in oncology, 1996-02, Vol.23 (1 Suppl 1), p.33

1996

Volltextzugriff (PDF)

The role of serotonin as a mediator of emesis induced by different stimuli

Supportive care in cancer, 1995-09, Vol.3 (5), p.285-290

1995

Volltextzugriff (PDF)

Epitheliale Ovarialkarzinome: Therapie der Frühstadien

Gynäkologie (Heidelberg, Germany), 2001-11, Vol.34 (11), p.1041-1049

2001

Volltextzugriff (PDF)

Anthracycline and trastuzumab in breast cancer treatment

Oncology (Williston Park, N.Y.), 2004-12, Vol.18 (14 Suppl 14), p.59

2004

Volltextzugriff (PDF)

Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer

Seminars in oncology, 1995-12, Vol.22 (6 Suppl 15), p.7

1995

Volltextzugriff (PDF)

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer

Journal of cancer research and clinical oncology, 1994-01, Vol.120 (3), p.173-178

1994

Volltextzugriff (PDF)

Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer

Cancer chemotherapy and pharmacology, 1990, Vol.26 (S1), p.S33-S35

1990

Volltextzugriff (PDF)

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

Annals of oncology, 2004-10, Vol.15 (10), p.1527-1534

2004

Volltextzugriff (PDF)

00096 PRE-OPERATIVE SELECTION CRITERIA FOR OPERABILITY IN RECURRENT OVARIAN CANCER (DESKTOP-OVAR)

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.78-78

2005

Volltextzugriff (PDF)

Primäre Chemotherapie

Onkologie (Heidelberg, Germany), 1998-12, Vol.4 (12), p.1131-1139

1998

Volltextzugriff (PDF)

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer

Seminars in oncology, 1997-02, Vol.24 (1 Suppl 3), p.S13

1997

Volltextzugriff (PDF)

Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions

Prostaglandins, 1986-05, Vol.31 (5), p.961-972

1986

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(90)
Deutsch
(47)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(68)
Science & Technology
(63)
Life Sciences & Biomedicine
(62)
Female
(51)
Adult
(30)
Oncology
(29)
Aged
(28)
Middle Aged
(28)
Biological And Medical Sciences
(27)
Medical Sciences
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Ovarian Neoplasms - Drug Therapy
(16)
Pharmacology. Drug Treatments
(15)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(14)
Chemotherapy
(14)
Health Care Sciences & Services
(12)
Neoplasm Staging
(12)
Antineoplastic Agents
(11)
Combined Modality Therapy
(11)
Epidemiology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial

Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes : a new approach to cancer immunotherapy

Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

Clinical phase I study with one-hour paclitaxel infusion

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma

Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial

Operative und medikamentöse Therapie des frühen Ovarialkarzinoms

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer

Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis

Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer

The role of serotonin as a mediator of emesis induced by different stimuli

Epitheliale Ovarialkarzinome: Therapie der Frühstadien

Anthracycline and trastuzumab in breast cancer treatment

Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer

Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

00096 PRE-OPERATIVE SELECTION CRITERIA FOR OPERABILITY IN RECURRENT OVARIAN CANCER (DESKTOP-OVAR)

Primäre Chemotherapie

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer

Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions

Suchergebnisse filtern